Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Progress in Natural Compounds/siRNA Co-delivery Employing Nanovehicles for Cancer Therapy
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, et al.
ACS Combinatorial Science (2020) Vol. 22, Iss. 12, pp. 669-700
Open Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

siRNA: Mechanism of action, challenges, and therapeutic approaches
Walhan Alshaer, Hadil Zureigat, Arwa Al Karaki, et al.
European Journal of Pharmacology (2021) Vol. 905, pp. 174178-174178
Closed Access | Times Cited: 259
Self-assembled peptide and protein nanostructures for anti-cancer therapy: Targeted delivery, stimuli-responsive devices and immunotherapy
Masoud Delfi, Rossella Sartorius, Milad Ashrafizadeh, et al.
Nano Today (2021) Vol. 38, pp. 101119-101119
Open Access | Times Cited: 193
Advances in tannic acid-incorporated biomaterials: Infection treatment, regenerative medicine, cancer therapy, and biosensing
Ashkan Bigham, Vahid Rahimkhoei, Payam Abasian, et al.
Chemical Engineering Journal (2021) Vol. 432, pp. 134146-134146
Closed Access | Times Cited: 158
Drug Delivery (Nano)Platforms for Oral and Dental Applications: Tissue Regeneration, Infection Control, and Cancer Management
Pooyan Makvandi, Uroš Josić, Masoud Delfi, et al.
Advanced Science (2021) Vol. 8, Iss. 8
Open Access | Times Cited: 145
Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects
Asal Jalal Abadi, Sepideh Mirzaei, Mahmood Khaksary Mahabady, et al.
Phytotherapy Research (2021) Vol. 36, Iss. 1, pp. 189-213
Closed Access | Times Cited: 145
Autophagy and cancer drug resistance in dialogue: Pre-clinical and clinical evidence
Yi Qin, Milad Ashrafizadeh, Vera Mongiardini, et al.
Cancer Letters (2023) Vol. 570, pp. 216307-216307
Closed Access | Times Cited: 145
Hyaluronic acid-based nanoplatforms for Doxorubicin: A review of stimuli-responsive carriers, co-delivery and resistance suppression
Milad Ashrafizadeh, Sepideh Mirzaei, Mohammad Gholami, et al.
Carbohydrate Polymers (2021) Vol. 272, pp. 118491-118491
Open Access | Times Cited: 133
Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects
Sepideh Mirzaei, Mohammad Gholami, Farid Hashemi, et al.
Drug Discovery Today (2021) Vol. 27, Iss. 2, pp. 436-455
Open Access | Times Cited: 127
STAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy response
Mehrdokht Sadrkhanloo, Maliheh Entezari, Sima Orouei, et al.
Pharmacological Research (2022) Vol. 182, pp. 106311-106311
Closed Access | Times Cited: 107
Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy
Mehrdad Hashemi, Marzieh Sadat Moosavi, Hedyeh Maghareh Abed, et al.
Pharmacological Research (2022) Vol. 184, pp. 106418-106418
Closed Access | Times Cited: 104
(Nano)platforms in bladder cancer therapy: Challenges and opportunities
Milad Ashrafizadeh, Ali Zarrabi, Hassan Karimi‐Maleh, et al.
Bioengineering & Translational Medicine (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 89
Dexamethasone: Insights into Pharmacological Aspects, Therapeutic Mechanisms, and Delivery Systems
Vijay Sagar Madamsetty, Reza Mohammadinejad, Ilona Uzielienè, et al.
ACS Biomaterials Science & Engineering (2022) Vol. 8, Iss. 5, pp. 1763-1790
Closed Access | Times Cited: 81
Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling
Maliheh Entezari, Maryam Ghanbarirad, Afshin Taheriazam, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 112963-112963
Open Access | Times Cited: 78
Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies
Mehrdad Hashemi, Mohammad Arad Zandieh, Yasmin Talebi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114392-114392
Open Access | Times Cited: 54
Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery
Yamei Hu, Zigang Dong, Kangdong Liu
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 43
MicroRNA-34 Family in Cancers: Role, Mechanism, and Therapeutic Potential
Junjiang Fu, Saber İmani, Mei-Yi Wu, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4723-4723
Open Access | Times Cited: 39
Wnt/β-Catenin Signaling as a Driver of Hepatocellular Carcinoma Progression: An Emphasis on Molecular Pathways
Mahshid Deldar Abad Paskeh, Sepideh Mirzaei, Milad Ashrafizadeh, et al.
Journal of Hepatocellular Carcinoma (2021) Vol. Volume 8, pp. 1415-1444
Open Access | Times Cited: 98
Chitosan‐based nanoscale systems for doxorubicin delivery: Exploring biomedical application in cancer therapy
Milad Ashrafizadeh, Kiavash Hushmandi, Sepideh Mirzaei, et al.
Bioengineering & Translational Medicine (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 62
Recent Advances and Challenges in Gene Delivery Mediated by Polyester-Based Nanoparticles
Anna Piperno, Maria Teresa Sciortino, Elena Giusto, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 5981-6002
Open Access | Times Cited: 60
Nanotechnological Approaches in Prostate Cancer Therapy: Integration of engineering and biology
Milad Ashrafizadeh, Shahin Aghamiri, Shing Cheng Tan, et al.
Nano Today (2022) Vol. 45, pp. 101532-101532
Open Access | Times Cited: 60
Stimulus-responsive drug/gene delivery system based on polyethylenimine cyclodextrin nanoparticles for potential cancer therapy
Hanieh Mousazadeh, Esat Bonabi, Nosratollah Zarghami
Carbohydrate Polymers (2021) Vol. 276, pp. 118747-118747
Closed Access | Times Cited: 57
Chitosan: A versatile bio-platform for breast cancer theranostics
Vijay Sagar Madamsetty, Shima Tavakol, Saeid Moghassemi, et al.
Journal of Controlled Release (2021) Vol. 341, pp. 733-752
Closed Access | Times Cited: 55
Overcoming doxorubicin resistance in cancer: siRNA-loaded nanoarchitectures for cancer gene therapy
Mahshid Deldar Abad Paskeh, Hamidreza Saebfar, Mahmood Khaksary Mahabady, et al.
Life Sciences (2022) Vol. 298, pp. 120463-120463
Open Access | Times Cited: 48
pH-Responsive, Adorned Nanoniosomes for Codelivery of Cisplatin and Epirubicin: Synergistic Treatment of Breast Cancer
Ali Moammeri, Koorosh Abbaspour, Alireza Zafarian, et al.
ACS Applied Bio Materials (2022) Vol. 5, Iss. 2, pp. 675-690
Open Access | Times Cited: 45
Imaging biomarkers for clinical applications in neuro-oncology: current status and future perspectives
Fang-Ying Chiu, Yun Yen
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 34
Page 1 - Next Page

Scroll to top